Fannin aims to deliver cost effective, high quality medicines, devices and diagnostic products, across a broad range of disciplines. Fannin achieves this depth and breath of activity through teams of highly skilled and dedicated business professionals, each with expert knowledge of their respective sectors and each exclusively focused on their specialist Division. At Fannin, it is recognised that in an increasingly sophisticated and busy healthcare system, it is no longer sufficient to simply sell a product. The company actively seeks to deliver cost effective combinations of value added service interventions, tailor made solutions and highly innovative technical products, in a responsible and ethical manner.

Fannin works closely with its suppliers to provide products which offer improved safety, reliability and value and endeavour to back these products up with excellent customer service and support.

Fannin has an active Regulatory Affairs department offering regulatory services to its suppliers which includes registrations, amendments, pharmacovigilence and quality review. A full European-wide regulatory and pharmacovigilance service is available on a consultancy basis.

http://www.fannin.ie/files/regulatory_a4_brochure.pdf

Fannin is a subsidiary of DCC plc, a leading public company, listed on the Irish and London stock exchange. The company benefits from DCC's immensely strong balance sheet, their encouragement of the entrepreneurial spirit, support of management initiatives and excellent track record in identifying, executing and integrating bolt-on acquisitions. (www.dcc.ie) Fannin currently employs over 100 dedicated sales professionals across the UK and Ireland giving it the scale and capacity to deliver results. It is also strengthened by 175 years of service providing it with the heritage to support its claims.

Fannin has 4 divisions –

Pharmaceutical – Fannin first established its Pharmacy Department in the 1890’s. In 2002 it strengthened its presence through its acquisition of TechnoPharm Limited who had rapidly developed a reputation for the introduction of high quality, innovative and cost effective medicines and services. Focused on the immuno-compromised and the critically ill it has developed a broad range of branded and generic value added compounds in the areas of oncology, haematology, microbiology, anaesthesia and parenteral nutrition. Dedicated to quality, the Pharmaceutical Division maintains the standards of GMP GPD and ISO 9001:2000 through a focused Regulatory team supported by highly skilled clinical sales specialists.

Critical Care - Fannin has provided innovative solutions to the needs of surgical and critical care teams for over 50 years. The company provides a cost-effective portfolio of highly innovative products for the anaesthesia, IV therapy and critical care markets.

Endosurgery - The EndoSurgery Division provides innovative solutions for minimally invasive surgery. The EndoSurgery division’s broad product range includes surgical stapling products, trocar systems, tissue retrieval sacs, hernia mesh, disposable laparoscopic instruments, and imaging systems. All the products are carefully sourced and Fannin works closely with its suppliers and partners to provide the right blend of quality, price and innovation. It is the mission of the EndoSurgery Division of Fannin to provide the best possible service and products in the most cost-effective manner possible.

Surgical - Through the acquisition of GU Medical, Fannin’s Surgical division offers a wide range of quality surgical instrumentation and is part of the PASA Framework Agreement for both reusable and single use instrumentation and members of ABHI. The company has gained leadership positions in urology, cardio-thoracic, vascular, neurosurgery, and general surgical instrument specialties. All surgical instruments offered by the GU Surgical division are also available worldwide via our Export Division.

Fannin is interested in finding any companies with products that need distribution within the UK and Ireland that fit within its divisional framework.

For the Pharmaceutical division, Fannin seeks opportunities primarily in the hospital sector and offers partners our sales, marketing and distribution strengths within the UK and Ireland plus our EU regulatory affairs service.

We are particularly interested in:

- Sales, marketing & distribution opportunities for the UK/ROI hospital injectables market (branded or generic)

-   Specialist / Hospital branded products requiring representation within Ireland (Haematology, Oncology, Rheumatology, Anaesthesia, anti-infectives

- Oral single ingredient anti-tuberculosis medicines for the UK

- Companies seeking regulatory consultancy across the EU but in particular UK and Ireland

- Co-marketing of hospital products / Joint ventures

- Biosimilar co-marketing partnerships

- Sunset-clause licence opportunities in UK and Ireland

- Territories: UK and Republic of Ireland

For the other divisions of the company Fannin is always keen to meet with any company that has CE marked devices within the surgical instrumentation, endosurgical, IV therapy, anaesthesia and Hospital consummables markets.